Deep Track Capital, LP 13D and 13G filings for Acumen Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 08:32 am Sale |
2023-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS |
Deep Track Capital, LP | 0 0.000% |
-3,952,000 (Position Closed) |
Filing |
| 2023-02-14 08:21 am Purchase |
2022-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS |
Deep Track Capital, LP | 3,952,000 9.660% |
1,537,083 (+63.65%) |
Filing |
| 2022-01-27 4:34 pm Purchase |
2022-01-24 | 13G | Acumen Pharmaceuticals, Inc. ABOS |
Deep Track Capital, LP | 2,414,917 5.970% |
2,414,917 (New Position) |
Filing |